Filing Details

Accession Number:
0001209191-14-068160
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-12 17:09:32
Reporting Period:
2014-11-07
Filing Date:
2014-11-12
Accepted Time:
2014-11-12 17:09:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333170 Nxstage Medical Inc. NXTM Electromedical & Electrotherapeutic Apparatus (3845) 043454702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341405 L Winifred Swan C/O Nxstage Medical, Inc.
350 Merrimack Street
Lawrence MA 01843
Svp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-07 16,666 $14.44 36,354 No 4 M Direct
Common Stock Disposition 2014-11-07 16,666 $16.25 19,688 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-11-07 16,666 $0.00 16,666 $14.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,334 2008-01-07 2014-12-06 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2014.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.92 to $16.40, inclusive. The reporting person undertakes to provide to NxStage Medical, any security holder of NxStage Medical, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.